Boehringer Ingelheim is sponsoring the prizes for the best Early Phase and Start up Phase projects in the category "biotech/pharma".
Boehringer Ingelheim is one of the world’s twenty leading pharmaceutical companies
Headquartered in Ingelheim, Germany, it operates globally with around 47,500 employees. The focus of the family-owned company is research, development, production, and marketing of new medications of high therapeutic value for human and veterinary medicine. The Boehringer Ingelheim Regional Center Vienna is responsible for Boehringer Ingelheim’s human pharmaceutical and animal health business in Austria as well as the clinical research in more than thirty countries in Central and Eastern Europe and Central Asia. It is the center for cancer research and a biopharmaceutical research, development and production hub within the international group. Boehringer Ingelheim is involved in basic research through the Research Institute of Molecular Pathology (IMP) in Vienna. This makes it the most research intensive pharmaceutical company in Austria. In 2015, the Regional Center Vienna employed 3,403 people, including 1,501 in Austria.
LISAvienna sponsors the prizes for the best Early Phase and Start up Phase projects in the category "medtech, IVD and digital health".
LISAvienna is the joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Labour and Economy and the city of Vienna, it contributes to the advancement of life sciences in Vienna. LISAvienna supports innovative biotech, pharmaceutical and medical technology companies in Vienna that develop and market new products, services and processes. The platform links these companies with development partners and key customers. As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.
- Information & Consulting: Tips and contacts relating to sponsorship, private financing options, infrastructure in Vienna, development partners, leading customers and internationalization
- Networking & Matching: Contacts for an improved exchange of experiences and knowledge transfer as well as contact with development partners, leading customers and investors worldwide
- Expertise: Analyses, background information, reports and studies relating to life sciences in Vienna
- Marketing: Electronic and printed news items from the field of life sciences in Vienna
Takeda is sponsoring the special award "Digitalisation in Life Science" for the best submission.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Our mission is to develop, manufacture and supply life-enhancing and life-sustaining medicines for the treatment of rare and complex diseases. In our work we are committed to our patients, employees and the environment.
In Austria, Takeda is the largest pharmaceutical employer. Every day, more than 4,500 employees help to ensure that medicines from Austria reach the whole world and that patients in Austria have access to innovative medicines from Takeda. Takeda's Austrian product portfolio helps patients in the fields of oncology, hemophilia and genetic diseases, gastroenterology and immunology, among others.